Copyright Reports & Markets. All rights reserved.

Global Aquaculture Therapeutics Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Aquaculture Therapeutics

      • 1.1 Definition of Aquaculture Therapeutics
      • 1.2 Aquaculture Therapeutics Segment by Type
        • 1.2.1 Global Aquaculture Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Formalin Solution
        • 1.2.3 Chorionic Gonadotropin
        • 1.2.4 Florfenicol
        • 1.2.5 Tricaine Methane Sulfonate
        • 1.2.6 Oxytetracycline
        • 1.2.7 Hydrogen Peroxide
      • 1.3 Aquaculture Therapeutics Segment by Applications
        • 1.3.1 Global Aquaculture Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Veterinary Pharmacies
        • 1.3.3 Veterinary Hospitals
        • 1.3.4 E-Commerce
        • 1.3.5 Veterinary Clinics
      • 1.4 Global Aquaculture Therapeutics Overall Market
        • 1.4.1 Global Aquaculture Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Aquaculture Therapeutics Production (2014-2025)
        • 1.4.3 North America Aquaculture Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Aquaculture Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Aquaculture Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Aquaculture Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Aquaculture Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Aquaculture Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Aquaculture Therapeutics
      • 2.3 Manufacturing Process Analysis of Aquaculture Therapeutics
      • 2.4 Industry Chain Structure of Aquaculture Therapeutics

      3 Development and Manufacturing Plants Analysis of Aquaculture Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Aquaculture Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Aquaculture Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Aquaculture Therapeutics Production and Capacity Analysis
      • 4.2 Aquaculture Therapeutics Revenue Analysis
      • 4.3 Aquaculture Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Aquaculture Therapeutics Regional Market Analysis

      • 5.1 Aquaculture Therapeutics Production by Regions
        • 5.1.1 Global Aquaculture Therapeutics Production by Regions
        • 5.1.2 Global Aquaculture Therapeutics Revenue by Regions
      • 5.2 Aquaculture Therapeutics Consumption by Regions
      • 5.3 North America Aquaculture Therapeutics Market Analysis
        • 5.3.1 North America Aquaculture Therapeutics Production
        • 5.3.2 North America Aquaculture Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Aquaculture Therapeutics Import and Export
      • 5.4 Europe Aquaculture Therapeutics Market Analysis
        • 5.4.1 Europe Aquaculture Therapeutics Production
        • 5.4.2 Europe Aquaculture Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Aquaculture Therapeutics Import and Export
      • 5.5 China Aquaculture Therapeutics Market Analysis
        • 5.5.1 China Aquaculture Therapeutics Production
        • 5.5.2 China Aquaculture Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Aquaculture Therapeutics Import and Export
      • 5.6 Japan Aquaculture Therapeutics Market Analysis
        • 5.6.1 Japan Aquaculture Therapeutics Production
        • 5.6.2 Japan Aquaculture Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Aquaculture Therapeutics Import and Export
      • 5.7 Southeast Asia Aquaculture Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Aquaculture Therapeutics Production
        • 5.7.2 Southeast Asia Aquaculture Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Aquaculture Therapeutics Import and Export
      • 5.8 India Aquaculture Therapeutics Market Analysis
        • 5.8.1 India Aquaculture Therapeutics Production
        • 5.8.2 India Aquaculture Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Aquaculture Therapeutics Import and Export

      6 Aquaculture Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Aquaculture Therapeutics Production by Type
      • 6.2 Global Aquaculture Therapeutics Revenue by Type
      • 6.3 Aquaculture Therapeutics Price by Type

      7 Aquaculture Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Aquaculture Therapeutics Consumption by Application
      • 7.2 Global Aquaculture Therapeutics Consumption Market Share by Application (2014-2019)

      8 Aquaculture Therapeutics Major Manufacturers Analysis

      • 8.1 TunaTech GmbH
        • 8.1.1 TunaTech GmbH Aquaculture Therapeutics Production Sites and Area Served
        • 8.1.2 TunaTech GmbH Product Introduction, Application and Specification
        • 8.1.3 TunaTech GmbH Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 ViAqua Therapeutics Ltd.
        • 8.2.1 ViAqua Therapeutics Ltd. Aquaculture Therapeutics Production Sites and Area Served
        • 8.2.2 ViAqua Therapeutics Ltd. Product Introduction, Application and Specification
        • 8.2.3 ViAqua Therapeutics Ltd. Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Alpharma Inc.
        • 8.3.1 Alpharma Inc. Aquaculture Therapeutics Production Sites and Area Served
        • 8.3.2 Alpharma Inc. Product Introduction, Application and Specification
        • 8.3.3 Alpharma Inc. Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Blue Ridge Aquaculture
        • 8.4.1 Blue Ridge Aquaculture Aquaculture Therapeutics Production Sites and Area Served
        • 8.4.2 Blue Ridge Aquaculture Product Introduction, Application and Specification
        • 8.4.3 Blue Ridge Aquaculture Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Cermaq ASA
        • 8.5.1 Cermaq ASA Aquaculture Therapeutics Production Sites and Area Served
        • 8.5.2 Cermaq ASA Product Introduction, Application and Specification
        • 8.5.3 Cermaq ASA Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Cooke Aquaculture
        • 8.6.1 Cooke Aquaculture Aquaculture Therapeutics Production Sites and Area Served
        • 8.6.2 Cooke Aquaculture Product Introduction, Application and Specification
        • 8.6.3 Cooke Aquaculture Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Nireus Aquaculture S.A.
        • 8.7.1 Nireus Aquaculture S.A. Aquaculture Therapeutics Production Sites and Area Served
        • 8.7.2 Nireus Aquaculture S.A. Product Introduction, Application and Specification
        • 8.7.3 Nireus Aquaculture S.A. Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Tassal group Ltd.
        • 8.8.1 Tassal group Ltd. Aquaculture Therapeutics Production Sites and Area Served
        • 8.8.2 Tassal group Ltd. Product Introduction, Application and Specification
        • 8.8.3 Tassal group Ltd. Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Nireus S.A.
        • 8.9.1 Nireus S.A. Aquaculture Therapeutics Production Sites and Area Served
        • 8.9.2 Nireus S.A. Product Introduction, Application and Specification
        • 8.9.3 Nireus S.A. Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Unima Group
        • 8.10.1 Unima Group Aquaculture Therapeutics Production Sites and Area Served
        • 8.10.2 Unima Group Product Introduction, Application and Specification
        • 8.10.3 Unima Group Aquaculture Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Nutreco Holding N.V.
      • 8.12 Kona Bay Marine Resources
      • 8.13 Royal Greenland
      • 8.14 Sea Watch International Ltd.
      • 8.15 Selonda Aquaculture S.A.
      • 8.16 StarKist Taylor Shellfish Inc.
      • 8.17 TriMarine International
      • 8.18 Seafood Company

      9 Development Trend of Analysis of Aquaculture Therapeutics Market

      • 9.1 Global Aquaculture Therapeutics Market Trend Analysis
        • 9.1.1 Global Aquaculture Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Aquaculture Therapeutics Regional Market Trend
        • 9.2.1 North America Aquaculture Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Aquaculture Therapeutics Forecast 2019-2025
        • 9.2.3 China Aquaculture Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Aquaculture Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Aquaculture Therapeutics Forecast 2019-2025
        • 9.2.6 India Aquaculture Therapeutics Forecast 2019-2025
      • 9.3 Aquaculture Therapeutics Market Trend (Product Type)
      • 9.4 Aquaculture Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Aquaculture Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The Farming or the culturing of aquatic animals like the fishes, algae, mollusks, crustaceans, aquatic plants and other aquatic organisms in different types of water is termed as Aquaculture. The cultivation process involves nurturing of these aquatic organism in the controlled condition either in fresh or in salt water. Later on these aquatic organisms are then harvested to be served as the source of nutrition or to be used for many other purposes. The aquatic animals are very sensitive and are prone to various epidemic diseases. Other factors affecting the aquatic cultured animals are Pathogens (e.g. bacteria, viruses, fungi and parasites) exist in all natural water bodies. At the same time crowded culture environment makes the causes high risk for infection and makes the fishes nervous. Crowding also results in fish knocking eventually leading to surface wounds which is a cause for inaction. These can be cured using several FDA approved antibiotics and other medicines. Apart from diseases medicines are used to improve the wellbeing of the fishes in the aquaculture. The list of drugs includes chorionic gonadotropin, formalin solution, florfenicol, oxytetracycline, tricaine methane sulfonate, hydrogen peroxide, sulfadimethoxine/ormetoprim combination, acetic acid, calcium chloride, calcium oxide, carbon dioxide gas, fuller’s earth, garlic (whole form), ice, magnesium sulfate, papain, potassium chloride, povidone iodine, sodium bicarbonate, sodium chloride, sodium sulfite, thiamine hydrochloride, urea and tannic acid. The above mentioned drugs take care of the aquatic animals fighting with several diseases which are not only harmful to the aquatic animals but are also harmful to the consumer. There are two different categories of diseases which affect the aquatic population viz. diseases due to pathogens which are indigenous to the local environment and exotic pathogens.
        A lot of advancements are taking place in the aquaculture therapeutics as there are several diseases affecting the animals cultured in the aquaculture. There are several diseases driving the aquaculture therapeutics market. Mostly these diseases are dependent on hygiene conditions that are to be maintained. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs are the factors expected to drive the growth of aquaculture therapeutics market. Also, the demand for aquaculture is rapidly growing day by day due to the decreasing number of the oceanic fish and increasing consumption of the fishes at a global level.

        The global Aquaculture Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Aquaculture Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aquaculture Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Aquaculture Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Aquaculture Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        TunaTech GmbH
        ViAqua Therapeutics Ltd.
        Alpharma Inc.
        Blue Ridge Aquaculture
        Cermaq ASA
        Cooke Aquaculture
        Nireus Aquaculture S.A.
        Tassal group Ltd.
        Nireus S.A.
        Unima Group
        Nutreco Holding N.V.
        Kona Bay Marine Resources
        Royal Greenland
        Sea Watch International Ltd.
        Selonda Aquaculture S.A.
        StarKist Taylor Shellfish Inc.
        TriMarine International
        Seafood Company

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Formalin Solution
        Chorionic Gonadotropin
        Florfenicol
        Tricaine Methane Sulfonate
        Oxytetracycline
        Hydrogen Peroxide

        Segment by Application
        Veterinary Pharmacies
        Veterinary Hospitals
        E-Commerce
        Veterinary Clinics

        Buy now